tiprankstipranks
N4 Pharma PLC (GB:N4P)
LSE:N4P

N4 Pharma (N4P) Financial Statements

2 Followers

N4 Pharma Financial Overview

N4 Pharma's market cap is currently ―. The company's EPS TTM is p-0.005; its P/E ratio is -0.91; N4 Pharma is scheduled to report earnings on September 18, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 1.92M£ 1.58M£ 1.78M£ 2.54M£ 3.56M
Total Assets£ 2.17M£ 1.61M£ 2.34M£ 2.82M£ 3.83M
Total Debt£ 0.00£ 0.00£ 0.00£ 0.00£ 0.00
Net Debt£ -1.92M£ -1.58M£ -1.78M£ -2.54M£ -3.56M
Total Liabilities£ 77.89K£ 220.77K£ 212.73K£ 123.33K£ 169.08K
Stockholders Equity£ 2.09M£ 1.39M£ 2.13M£ 2.69M£ 3.66M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

N4 Pharma Earnings and Revenue History

N4 Pharma Debt to Assets

N4 Pharma Cash Flow

N4 Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis